Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to numerous complications, including secondary bacterial infections that worsen clinical outcomes. Among these, Legionella pneumophila, the causative agent of Legionnaires' disease, poses a significant threat, particularly in  critically ill patients. This report presents a case of a 63-year-old male with severe COVID-19 complicated by Legionnaires' disease, resulting in acute respiratory distress syndrome. Despite requiring intensive care and mechanical ventilation, early diagnosis and timely administration of levofloxacin led to a successful recovery. The case highlights the challenges of distinguishing Legionnaires' disease fromCOVID-19 due to overlapping symptoms and underscores the importance of rapid diagnostic testing. Early identification and targeted antibiotic therapy are crucial in improving patient outcomes. This report also emphasizes the necessity of considering bacterial co-infections in critically ill COVID-19 patients and the need for vigilant monitoring to prevent fatal complications.